CLL: Mayo Clinic's approach to diagnosis

Feb 17, 2020 | Justin McClanahan, Moderator | @JustinMcClanahan


Approximately 20,000 patients will be diagnosed with chronic lymphocytic leukemia (CLL) in the United States alone in 2019. Many of these patients will be in the early-stage of their disease at the time of their diagnosis and will not meet indications for therapy (learn more about this period known as watch & wait).

It is now possible for Mayo Clinic hematologists to identify several prognostic markers to individually predict which patients are at a higher risk of progression. Learn more about the five variables providers use to determine who is at a higher risk in Dr. Parikh's video below:

Are you or a loved one living with CLL and would like to talk with others who are walking the same path? Join the Blood Cancers & Disorders support group on Connect and discover a community of real people with similar experiences. Some discussions to get you started:

Mayo Clinic CLL Clinical Trials

Interested in more newsfeed posts like this? Go to the Hematology blog.

Please sign in or register to post a reply.